The effects of diabetes on lipoprotein particle sizes were assessed us
ing samples from 94 subjects with non-insulin-dependent diabetes melli
tus. From a larger population of nondiabetic subjects who showed norma
l glucose tolerance, we selected an exact match in terms of age, sex,
and menopausal status. We designed a protocol to make nondenaturing gr
adient gels for the resolution of LDL subfractions and generated two m
easures of LDL size: diameter of the predominant LDL species and propo
rtion of LDL cholesterol (LDL-C) in particles larger than 25.5 nm (lar
ge LDL-C). Similarly, we made two measures of HDL size, large HDL chol
esterol (HDL-C) and large HDL-apoAI, which represent the proportion of
HDL-C and apoAI, respectively, occurring on particles larger than HDL
(3). In pairwise comparisons, diabetes was associated with significant
ly (P < .004) smaller lipoprotein particles for all measures except la
rge HDL-C. Each of the size measures was significantly and positively
correlated with each of the others, suggesting that common metabolic m
echanisms influence lipoprotein particle sizes across classes of lipop
roteins. In addition, each of the size measures was correlated with a
variety of measures of HDL and beta-lipoprotein concentrations, which
included HDL-C, LDL-C, triglycerides, and apoAI, apoB, and apoE. We us
ed stepwise regression analyses to select from the measures of lipopro
tein concentrations those independently correlated with each of the li
poprotein size measures. After adjusting for these metabolic correlate
s of lipoprotein size measures, we found the effect of diabetes on lip
oprotein size measures was no longer significant except for a modest e
ffect (P = .027) on large HDL-apoAI. These results suggest that diabet
es alters aspects of lipoprotein metabolism that result in modificatio
n of lipoprotein particle sizes.